December 10, 2013
Speaking at hearings for the industry held by the Central Social Insurance Medical Council’s Expert Subcommittee on NHI Drug Pricing Affairs on December 6, Ichiro Umeda, chairman of the Pharmaceutical Research and Manufacturers of America’s (PhRMA) Japan-based Executive Committee and...read more